Predilytics Secures $10M Series C Funding

predilyticsPredilytics, a Burlington, MA-based healthcare information technology company, secured an additional $10m Series C funding.

The round was led by Qualcomm Incorporated, through Qualcomm Ventures, with participation from existing investors Flybridge Capital Partners, Foundation Medical, and Highland Capital.

The company intends to use the funds to continue to grow and develop its technology.

Founded in 2011 and led by Chris Coloian, President and CEO, Predilytics applies patented, machine-learning analytic tools to transform structured and unstructured client data, along with external data sources, into actionable insights for healthcare organizations to understand consumer behavior, optimize and precisely target care delivery, and improve population health.



Join the discussion